5-141640080-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173828.5(RELL2):c.664C>A(p.Leu222Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000886 in 1,613,350 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_173828.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RELL2 | NM_173828.5 | c.664C>A | p.Leu222Met | missense_variant | 5/7 | ENST00000297164.8 | NP_776189.3 | |
FCHSD1 | NM_033449.3 | c.*1418G>T | 3_prime_UTR_variant | 20/20 | ENST00000435817.7 | NP_258260.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RELL2 | ENST00000297164.8 | c.664C>A | p.Leu222Met | missense_variant | 5/7 | 1 | NM_173828.5 | ENSP00000297164.3 | ||
FCHSD1 | ENST00000435817 | c.*1418G>T | 3_prime_UTR_variant | 20/20 | 1 | NM_033449.3 | ENSP00000399259.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 246974Hom.: 0 AF XY: 0.0000374 AC XY: 5AN XY: 133850
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461222Hom.: 1 Cov.: 35 AF XY: 0.0000894 AC XY: 65AN XY: 726934
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152128Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.664C>A (p.L222M) alteration is located in exon 5 (coding exon 5) of the RELL2 gene. This alteration results from a C to A substitution at nucleotide position 664, causing the leucine (L) at amino acid position 222 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at